Logotype for Laurus Labs Ltd

Laurus Labs (LAURUSLABS) investor relations material

Laurus Labs Q2 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Laurus Labs Ltd
Q2 25/26 earnings summary23 Oct, 2025

Executive summary

  • Achieved strong growth in Q2 and H1 FY26, with H1 revenue at ₹3,223 crore, up 33% year-over-year, driven by robust demand in ARV, CDMO, and Generics segments, and continued investments in capacity and technology platforms.

  • EBITDA reached ₹818 crore with a margin of 25.4%, reflecting improved operational execution and business mix.

  • Allotted 532 acres in Vizag for a new pharma complex, planning $600 million investment over eight years.

  • Interim dividend of ₹0.80 per share declared for FY 2025-26.

  • Unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, were approved by the Board on October 23, 2025.

Financial highlights

  • Q2 FY26 consolidated revenue reached ₹1,653.47 crore, up 35% year-over-year; H1 revenue at ₹3,223 crore, up 33%.

  • Gross margin for Q2 and H1 at ~60%; EBITDA margin for Q2 at 26% and H1 at 25.4%.

  • Q2 profit after tax at ₹194.49 crore; H1 profit after tax at ₹356.17 crore.

  • Net debt at ₹2,100 crore; debt/EBITDA improved to 1.3x from 1.8x sequentially and 3.4x year-over-year.

  • Operating cash flow for H1 FY26 was ₹1,093 crore; CAPEX at ₹489 crore (15% of revenues).

Outlook and guidance

  • Confident in improved growth for the rest of the year, with ARV sales expected around ₹2,500 crore ± ₹200 crore.

  • CDMO segment expected to continue strong growth, with ongoing investments in capacity and technology.

  • Underlying EBITDA margins anticipated to remain higher, driven by better asset utilization and product mix.

  • Animal health revenues anticipated to contribute meaningfully from next fiscal year.

  • The Board approved a composite scheme of arrangement involving demerger and amalgamation, pending NCLT approval.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q3 25/2623 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q3 25/2623 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Laurus Labs Limited, a pharmaceutical company, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and formulations in India. It involves in the development of antiviral APIs; generic APIs for hepatitis C and HIV Darunavir tablets; and oncology BCS class II drugs. The company also develops and commercializes single super specialty products comprising linezolid and formoterol. The company was incorporated in 2005 and is based in Hyderabad, India.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage